Authors
Sam S Lee, Yingchao Xue, Ang Li, Nina Rossa Haddad, Leigh Curvin-Aquilla, Arieana Johnson, Aiden Willis, Jeremy C Lee, Joshua Kim, Elizabeth Winnicki, Amanda Ruci, Iralde Sicilia, Zhaobo Liu, Justin Blumenthal, Andrew Huang, Aaron Won, Jiaxuan Qi, Dianzheng Yu, Minji Park, Charles Kirby, Amy van Ee, Hana Minsky, Ramon Garcia-Rodenas, Ella Jung, James Liu, Luis A Garza
Published in
The Journal of investigative dermatology. Nov 10, 2026. Epub Nov 10, 2026.
Abstract
Cellular therapy is a promising modality but requires optimization in human subjects, particularly for solid organs. Volar skin of the palms and soles is adapted to mechanical stress through a thick epidermis and dense extracellular matrix. These features are reduced in non-volar skin, increasing vulnerability at high-pressure sites such as prosthetic limb interfaces. Volar fibroblasts can partially reprogram non-volar skin toward volar characteristics, suggesting a strategy to prevent pressure related injury. We tested whether combining volar fibroblast therapy with a collagen/polymethyl methacrylate (PMMA) scaffold could enhance remodeling by providing additional niches for ectopic fibroblast engraftment. Healthy volunteers received injections of vehicle, scalp fibroblasts, or volar fibroblasts, with or without collagen/PMMA, into non-volar skin. Durometer, optical coherence tomography, and histology showed volar-like changes, including increased skin firmness, epidermal thickness, papillary elastin, and collagen fiber density after treatment. Single-cell and spatial transcriptomics revealed activation of skin development, keratinocyte differentiation, extracellular matrix organization, and morphogenesis pathways. Collagen/PMMA promoted fibroblast, immune, and endothelial cell accumulation, consistent with a scaffold-associated tissue response across treatment groups. These findings distinguish volar fibroblast-associated changes in skin identity from collagen/PMMA-induced stromal remodeling, which includes features of a foreign body response and may contain inflammatory and fibrotic/myofibroblast-associated components.
PMID:
43008965
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0